» Articles » PMID: 35235615

Kynurenine-3-monooxygenase (KMO) Broadly Inhibits Viral Infections Via Triggering NMDAR/Ca2+ Influx and CaMKII/ IRF3-mediated IFN-β Production

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2022 Mar 2
PMID 35235615
Authors
Affiliations
Soon will be listed here.
Abstract

Tryptophan (Trp) metabolism through the kynurenine pathway (KP) is well known to play a critical function in cancer, autoimmune and neurodegenerative diseases. However, its role in host-pathogen interactions has not been characterized yet. Herein, we identified that kynurenine-3-monooxygenase (KMO), a key rate-limiting enzyme in the KP, and quinolinic acid (QUIN), a key enzymatic product of KMO enzyme, exerted a novel antiviral function against a broad range of viruses. Mechanistically, QUIN induced the production of type I interferon (IFN-I) via activating the N-methyl-d-aspartate receptor (NMDAR) and Ca2+ influx to activate Calcium/calmodulin-dependent protein kinase II (CaMKII)/interferon regulatory factor 3 (IRF3). Importantly, QUIN treatment effectively inhibited viral infections and alleviated disease progression in mice. Furthermore, kmo-/- mice were vulnerable to pathogenic viral challenge with severe clinical symptoms. Collectively, our results demonstrated that KMO and its enzymatic product QUIN were potential therapeutics against emerging pathogenic viruses.

Citing Articles

Association between Statins Administration and Influenza Susceptibility: A Systematic Review and Meta-Analysis of Longitudinal Studies.

Wu F, Wang C, Li S, Ye Y, Cui M, Liu Y Viruses. 2024; 16(2).

PMID: 38400053 PMC: 10893112. DOI: 10.3390/v16020278.


Special Issue: "Innate Immunity to Virus Infection, 1st Edition".

Wang C, Ma F, Sun C Viruses. 2023; 15(10).

PMID: 37896837 PMC: 10612017. DOI: 10.3390/v15102060.


A Transcriptional Analysis of Cattle Immune Cells Reveals a Central Role of Type 1 Interferon in the In Vitro Innate Immune Response against .

Blanco F, Bigi M, Garcia E, Elola M, Vazquez C, Bigi F Pathogens. 2023; 12(9).

PMID: 37764968 PMC: 10536033. DOI: 10.3390/pathogens12091159.


The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC.

Cysique L, Jakabek D, Bracken S, Allen-Davidian Y, Heng B, Chow S Ann Clin Transl Neurol. 2023; 10(8):1338-1352.

PMID: 37318955 PMC: 10424655. DOI: 10.1002/acn3.51825.


Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions.

Jovanovic F, Jovanovic V, Knezevic N Cells. 2023; 12(8).

PMID: 37190087 PMC: 10136661. DOI: 10.3390/cells12081178.


References
1.
Thomas T, Stefanoni D, Reisz J, Nemkov T, Bertolone L, Francis R . COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020; 5(14). PMC: 7453907. DOI: 10.1172/jci.insight.140327. View

2.
Fujigaki H, Yamamoto Y, Saito K . L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences. Neuropharmacology. 2016; 112(Pt B):264-274. DOI: 10.1016/j.neuropharm.2016.01.011. View

3.
Moffett J, Arun P, Puthillathu N, Vengilote R, Ives J, Badawy A . Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD Synthesis During Inflammation and Infection. Front Immunol. 2020; 11:31. PMC: 7047773. DOI: 10.3389/fimmu.2020.00031. View

4.
Khanna K, Bonneau R, Kinchington P, Hendricks R . Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity. 2003; 18(5):593-603. PMC: 2871305. DOI: 10.1016/s1074-7613(03)00112-2. View

5.
Zhao J, Li R, Li Y, Chen J, Feng F, Sun C . Broadly Antiviral Activities of TAP1 through Activating the TBK1-IRF3-Mediated Type I Interferon Production. Int J Mol Sci. 2021; 22(9). PMC: 8125511. DOI: 10.3390/ijms22094668. View